Table 2.
Intervention in systemic environment to rejuvenate function of tissue-specific stem cells.
Intervening approach | Target cell | Mechanism | Rejuvenation on function | References |
---|---|---|---|---|
Frizzled-related protein 3 (sFRP3) incubation | MuSCs | suppression of Wnt signaling | proliferative potential; muscle regeneration | [22] |
Dickkopf-1 (Dkk1) injection | MuSCs | suppression of Wnt signaling | muscle regeneration | [22] |
TGF-beta receptor kinase inhibitor | MuSCs | attenuating TGFβ signlling | regenerative potential | [21] |
Recombinant GDF11 injection | MuSCs | unknown | regenerative potential | [35] |
Oxytocin | MuSCs | activation of MAPK/ERK signaling | MuSC activation and proliferation; regenerative potential | [91] |
Recombinant GDF11 injection | NSCs | activation of TGFβ signaling | self-renewal; differentiation potential; neurogenesis | [36] |
GnRH I injection | NSCs | unknown | neuronesis; cognitive function | [87] |
CCL11-specific neutralizing antibody | NSCs | unknown | neuronesis; cognitive function | [37] |
N-acetylcysteine incubation | MSCs | Scavenging reactive oxygen species (ROS) | aging phenotypes | [85] |
4-hydroxytamoxifen (4-OHT) injection | Skin | blockade of NF-κB | age-associated gene expression; proliferation | [86] |
Recombinant GDF11 injection | Renal Epithelial cell | Upregulating ERK1/2 pathway | proliferative capacity; renal repair | [93] |